Multiple studies show major lack of public knowledge about HPV vaccine and cancer prevention
Despite the fact that the human papillomavirus (HPV) vaccine has been available in the U.S. for over 10 years and remains the only vaccine to protect against multiple types of cancer, several recent studies show that public knowledge about the vaccine and HPV’s relationship to cancer remains low.
HPV is responsible for 90% of cervical and anal cancers, and 70% of oropharyngeal (throat) cancers.
The first-generation HPV...
Research finds evidence HPV vaccine is improving herd immunity
A study from researchers at The University of Texas MD Anderson Cancer Center found that the prevalence of the types of oral human papillomavirus...
Assets and obstacles in the fight to prevent HPV-related cancers
Despite the availability of vaccines that could prevent the majority of cancers caused by the human papillomavirus (HPV), the incidence of...
Praise for the new HPV vaccine and its power to prevent cancer
The Food and Drug Administration’s (FDA) approval of a new vaccine that targets five additional strains of human papillomavirus (HPV) fortifies a proven cancer-prevention weapon, according to Ronald DePinho, M.D., president of MD Anderson Cancer Center.
The FDA greenlighted use of Gardasil 9 for the prevention of certain cancers caused by nine HPV strains – five more than its predecessor, Gardasil. The FDA said Gardasil 9 has the...
